The Cambridge Health Alliance and Bristol-Myers Squibb are running one trial into the efficacy, safety and tolerability of aripiprazole in children with ASD. Clinical Trials Gov Ref: NCT00308074. For more details, please see An open-label trial of aripiprazole in autism spectrum disorders Full Item(Open in New Window).
Drexel University is running one trial into the use of aripiprazole. Clinical Trials Gov Ref: NCT00208533. For more details, please see Aripiprazole in children with autism: A pilot study Full Item(Open in New Window).
The National Institute of Mental Health is running a trial into the use of Aripiprazole. For more details, please see Evaluating the effectiveness of aripiprazole and D-cycloserine to treat symptoms associated with autism Clinical Trials Gov Ref: NCT00198107 Full Item(Open in New Window).
The University of Medicine and Dentistry New Jersey is running one trial into the use of aripiprazole. Clinical Trials Gov Ref: NCT00468130. For more details, please see Efficacy of aripiprazole versus placebo in the reduction of aggressive and aberrant behavior in autistic children Full Item(Open in New Window).